NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXD3
|
ENSG00000187140.4 | forkhead box D3 |
FOXI1
|
ENSG00000168269.7 | forkhead box I1 |
FOXF1
|
ENSG00000103241.5 | forkhead box F1 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_24645078 | 1.38 |
ENST00000264463.4
|
CDH10
|
cadherin 10, type 2 (T2-cadherin) |
chr4_+_75174180 | 1.05 |
ENST00000413830.1
|
EPGN
|
epithelial mitogen |
chr4_-_153303658 | 0.87 |
ENST00000296555.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr5_+_102200948 | 0.78 |
ENST00000511477.1
ENST00000506006.1 ENST00000509832.1 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr3_+_178865887 | 0.72 |
ENST00000477735.1
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
chr13_-_86373536 | 0.70 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
chr21_+_17791648 | 0.64 |
ENST00000602892.1
ENST00000418813.2 ENST00000435697.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr12_+_25348186 | 0.64 |
ENST00000555711.1
ENST00000556885.1 ENST00000554266.1 ENST00000556351.1 ENST00000556927.1 ENST00000556402.1 ENST00000553788.1 |
LYRM5
|
LYR motif containing 5 |
chr2_-_188312971 | 0.60 |
ENST00000410068.1
ENST00000447403.1 ENST00000410102.1 |
CALCRL
|
calcitonin receptor-like |
chr15_+_76352178 | 0.59 |
ENST00000388942.3
|
C15orf27
|
chromosome 15 open reading frame 27 |
chr11_+_27076764 | 0.55 |
ENST00000525090.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr2_-_111291587 | 0.55 |
ENST00000437167.1
|
RGPD6
|
RANBP2-like and GRIP domain containing 6 |
chr8_+_97597148 | 0.55 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
chr12_+_51318513 | 0.53 |
ENST00000332160.4
|
METTL7A
|
methyltransferase like 7A |
chr3_+_177159744 | 0.52 |
ENST00000439009.1
|
LINC00578
|
long intergenic non-protein coding RNA 578 |
chr9_-_3469181 | 0.52 |
ENST00000366116.2
|
AL365202.1
|
Uncharacterized protein |
chr14_-_36990061 | 0.52 |
ENST00000546983.1
|
NKX2-1
|
NK2 homeobox 1 |
chr2_-_152146385 | 0.51 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr1_+_184020830 | 0.51 |
ENST00000533373.1
ENST00000423085.2 |
TSEN15
|
TSEN15 tRNA splicing endonuclease subunit |
chr4_-_99578776 | 0.50 |
ENST00000515287.1
|
TSPAN5
|
tetraspanin 5 |
chr2_-_178129551 | 0.50 |
ENST00000430047.1
|
NFE2L2
|
nuclear factor, erythroid 2-like 2 |
chr2_+_232575168 | 0.48 |
ENST00000440384.1
|
PTMA
|
prothymosin, alpha |
chr3_-_195310802 | 0.48 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr15_+_96869165 | 0.48 |
ENST00000421109.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr7_+_106415457 | 0.46 |
ENST00000490162.2
ENST00000470135.1 |
RP5-884M6.1
|
RP5-884M6.1 |
chrX_+_22050546 | 0.46 |
ENST00000379374.4
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr14_-_54418598 | 0.46 |
ENST00000609748.1
ENST00000558961.1 |
BMP4
|
bone morphogenetic protein 4 |
chr1_+_184020811 | 0.45 |
ENST00000361641.1
|
TSEN15
|
TSEN15 tRNA splicing endonuclease subunit |
chr4_-_140544386 | 0.45 |
ENST00000561977.1
|
RP11-308D13.3
|
RP11-308D13.3 |
chr5_-_142065612 | 0.45 |
ENST00000360966.5
ENST00000411960.1 |
FGF1
|
fibroblast growth factor 1 (acidic) |
chr13_-_40924439 | 0.44 |
ENST00000400432.3
|
RP11-172E9.2
|
RP11-172E9.2 |
chr1_+_95616933 | 0.43 |
ENST00000604203.1
|
RP11-57H12.6
|
TMEM56-RWDD3 readthrough |
chr7_+_129906660 | 0.43 |
ENST00000222481.4
|
CPA2
|
carboxypeptidase A2 (pancreatic) |
chr10_-_98031310 | 0.42 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
chr8_+_79428539 | 0.41 |
ENST00000352966.5
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
chr5_-_111091948 | 0.41 |
ENST00000447165.2
|
NREP
|
neuronal regeneration related protein |
chr3_-_168864315 | 0.41 |
ENST00000475754.1
ENST00000484519.1 |
MECOM
|
MDS1 and EVI1 complex locus |
chr17_+_4692230 | 0.40 |
ENST00000331264.7
|
GLTPD2
|
glycolipid transfer protein domain containing 2 |
chr8_-_95449155 | 0.40 |
ENST00000481490.2
|
FSBP
|
fibrinogen silencer binding protein |
chr17_+_72426891 | 0.39 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr10_-_98031265 | 0.39 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
chr1_-_57431679 | 0.38 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
chr9_-_99064386 | 0.38 |
ENST00000375262.2
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
chr11_-_111781554 | 0.38 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr2_+_28974489 | 0.37 |
ENST00000455580.1
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme |
chr2_-_166702601 | 0.37 |
ENST00000428888.1
|
AC009495.4
|
AC009495.4 |
chr11_+_63304273 | 0.36 |
ENST00000439013.2
ENST00000255688.3 |
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3 |
chr1_+_164528866 | 0.36 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr15_+_96904487 | 0.35 |
ENST00000600790.1
|
AC087477.1
|
Uncharacterized protein |
chr3_-_178865747 | 0.34 |
ENST00000435560.1
|
RP11-360P21.2
|
RP11-360P21.2 |
chr12_+_25348139 | 0.33 |
ENST00000557540.2
ENST00000381356.4 |
LYRM5
|
LYR motif containing 5 |
chrX_+_105936982 | 0.33 |
ENST00000418562.1
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr2_+_171640291 | 0.33 |
ENST00000409885.1
|
ERICH2
|
glutamate-rich 2 |
chr9_-_100000957 | 0.33 |
ENST00000366109.2
ENST00000607322.1 |
RP11-498P14.5
|
RP11-498P14.5 |
chr12_+_80838126 | 0.32 |
ENST00000266688.5
|
PTPRQ
|
protein tyrosine phosphatase, receptor type, Q |
chr8_+_52730143 | 0.32 |
ENST00000415643.1
|
AC090186.1
|
Uncharacterized protein |
chr5_-_142077569 | 0.32 |
ENST00000407758.1
ENST00000441680.2 ENST00000419524.2 |
FGF1
|
fibroblast growth factor 1 (acidic) |
chr15_-_76352069 | 0.32 |
ENST00000305435.10
ENST00000563910.1 |
NRG4
|
neuregulin 4 |
chr11_+_65657875 | 0.32 |
ENST00000312579.2
|
CCDC85B
|
coiled-coil domain containing 85B |
chr14_+_76776957 | 0.31 |
ENST00000512784.1
|
ESRRB
|
estrogen-related receptor beta |
chrX_+_153769446 | 0.31 |
ENST00000422680.1
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
chr9_-_99064429 | 0.31 |
ENST00000375263.3
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
chr11_+_113930955 | 0.31 |
ENST00000535700.1
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr17_-_40215075 | 0.31 |
ENST00000436535.3
|
ZNF385C
|
zinc finger protein 385C |
chr3_-_168864427 | 0.31 |
ENST00000468789.1
|
MECOM
|
MDS1 and EVI1 complex locus |
chr13_+_97928395 | 0.30 |
ENST00000445661.2
|
MBNL2
|
muscleblind-like splicing regulator 2 |
chr11_-_108464321 | 0.30 |
ENST00000265843.4
|
EXPH5
|
exophilin 5 |
chr2_-_202222091 | 0.30 |
ENST00000405148.2
ENST00000392257.3 ENST00000439709.1 |
ALS2CR12
|
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12 |
chr1_+_164529004 | 0.30 |
ENST00000559240.1
ENST00000367897.1 ENST00000540236.1 ENST00000401534.1 |
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr4_+_165675269 | 0.30 |
ENST00000507311.1
|
RP11-294O2.2
|
RP11-294O2.2 |
chr11_+_17316870 | 0.30 |
ENST00000458064.2
|
NUCB2
|
nucleobindin 2 |
chr11_-_46639436 | 0.30 |
ENST00000532281.1
|
HARBI1
|
harbinger transposase derived 1 |
chr1_+_12524965 | 0.30 |
ENST00000471923.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr12_+_28605426 | 0.29 |
ENST00000542801.1
|
CCDC91
|
coiled-coil domain containing 91 |
chr13_-_36050819 | 0.29 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
chr1_-_57045228 | 0.28 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr9_+_26956371 | 0.27 |
ENST00000380062.5
ENST00000518614.1 |
IFT74
|
intraflagellar transport 74 homolog (Chlamydomonas) |
chr6_+_53794780 | 0.27 |
ENST00000505762.1
ENST00000511369.1 ENST00000431554.2 |
MLIP
RP11-411K7.1
|
muscular LMNA-interacting protein RP11-411K7.1 |
chr15_-_38519066 | 0.27 |
ENST00000561320.1
ENST00000561161.1 |
RP11-346D14.1
|
RP11-346D14.1 |
chr9_-_39239171 | 0.27 |
ENST00000358144.2
|
CNTNAP3
|
contactin associated protein-like 3 |
chr2_-_207078154 | 0.26 |
ENST00000447845.1
|
GPR1
|
G protein-coupled receptor 1 |
chr4_-_147442817 | 0.26 |
ENST00000507030.1
|
SLC10A7
|
solute carrier family 10, member 7 |
chr17_+_67498396 | 0.26 |
ENST00000588110.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
chr7_+_116654958 | 0.26 |
ENST00000449366.1
|
ST7
|
suppression of tumorigenicity 7 |
chr17_-_36358166 | 0.26 |
ENST00000537432.1
|
TBC1D3
|
TBC1 domain family, member 3 |
chr2_+_191208791 | 0.26 |
ENST00000423767.1
ENST00000451089.1 |
INPP1
|
inositol polyphosphate-1-phosphatase |
chr4_-_99850243 | 0.26 |
ENST00000280892.6
ENST00000511644.1 ENST00000504432.1 ENST00000505992.1 |
EIF4E
|
eukaryotic translation initiation factor 4E |
chr13_+_52598827 | 0.25 |
ENST00000521776.2
|
UTP14C
|
UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) |
chr1_-_101360331 | 0.25 |
ENST00000416479.1
ENST00000370113.3 |
EXTL2
|
exostosin-like glycosyltransferase 2 |
chr5_+_68665608 | 0.25 |
ENST00000509734.1
ENST00000354868.5 ENST00000521422.1 ENST00000354312.3 ENST00000345306.6 |
RAD17
|
RAD17 homolog (S. pombe) |
chr4_+_184365744 | 0.25 |
ENST00000504169.1
ENST00000302350.4 |
CDKN2AIP
|
CDKN2A interacting protein |
chr1_+_117963209 | 0.25 |
ENST00000449370.2
|
MAN1A2
|
mannosidase, alpha, class 1A, member 2 |
chr11_-_111781610 | 0.25 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr2_-_165698662 | 0.24 |
ENST00000194871.6
ENST00000445474.2 |
COBLL1
|
cordon-bleu WH2 repeat protein-like 1 |
chr4_+_166794383 | 0.24 |
ENST00000061240.2
ENST00000507499.1 |
TLL1
|
tolloid-like 1 |
chr6_-_134861089 | 0.24 |
ENST00000606039.1
|
RP11-557H15.4
|
RP11-557H15.4 |
chr10_-_61122220 | 0.24 |
ENST00000422313.2
ENST00000435852.2 ENST00000442566.3 ENST00000373868.2 ENST00000277705.6 ENST00000373867.3 ENST00000419214.2 |
FAM13C
|
family with sequence similarity 13, member C |
chr2_+_181988620 | 0.24 |
ENST00000428474.1
ENST00000424655.1 |
AC104820.2
|
AC104820.2 |
chr14_+_51026926 | 0.24 |
ENST00000557735.1
|
ATL1
|
atlastin GTPase 1 |
chr9_+_108006880 | 0.24 |
ENST00000374723.1
ENST00000374720.3 ENST00000374724.1 |
SLC44A1
|
solute carrier family 44 (choline transporter), member 1 |
chr1_+_2258581 | 0.24 |
ENST00000600779.1
|
AL589739.1
|
Uncharacterized protein |
chr11_+_114549108 | 0.24 |
ENST00000389586.4
ENST00000375475.5 |
NXPE2
|
neurexophilin and PC-esterase domain family, member 2 |
chr2_-_211341411 | 0.23 |
ENST00000233714.4
ENST00000443314.1 ENST00000441020.3 ENST00000450366.2 ENST00000431941.2 |
LANCL1
|
LanC lantibiotic synthetase component C-like 1 (bacterial) |
chr8_-_72274467 | 0.23 |
ENST00000340726.3
|
EYA1
|
eyes absent homolog 1 (Drosophila) |
chr2_-_106054952 | 0.23 |
ENST00000336660.5
ENST00000393352.3 ENST00000607522.1 |
FHL2
|
four and a half LIM domains 2 |
chr4_-_74486109 | 0.23 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr17_-_77967433 | 0.23 |
ENST00000571872.1
|
TBC1D16
|
TBC1 domain family, member 16 |
chr7_+_23637763 | 0.23 |
ENST00000410069.1
|
CCDC126
|
coiled-coil domain containing 126 |
chr10_-_4720333 | 0.23 |
ENST00000430998.2
|
LINC00704
|
long intergenic non-protein coding RNA 704 |
chr1_-_8000872 | 0.23 |
ENST00000377507.3
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9 |
chr5_-_42811986 | 0.22 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr1_+_239882842 | 0.22 |
ENST00000448020.1
|
CHRM3
|
cholinergic receptor, muscarinic 3 |
chr3_+_178866199 | 0.22 |
ENST00000263967.3
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
chr18_-_25616519 | 0.22 |
ENST00000399380.3
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal) |
chr9_+_42671887 | 0.22 |
ENST00000456520.1
ENST00000377391.3 |
CBWD7
|
COBW domain containing 7 |
chr8_+_74903580 | 0.22 |
ENST00000284818.2
ENST00000518893.1 |
LY96
|
lymphocyte antigen 96 |
chr5_+_147691979 | 0.22 |
ENST00000274565.4
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative) |
chr12_-_15865844 | 0.22 |
ENST00000543612.1
|
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
chr8_-_90993869 | 0.22 |
ENST00000517772.1
|
NBN
|
nibrin |
chr20_+_9049742 | 0.22 |
ENST00000437503.1
|
PLCB4
|
phospholipase C, beta 4 |
chr7_+_116451100 | 0.22 |
ENST00000464223.1
ENST00000484325.1 |
CAPZA2
|
capping protein (actin filament) muscle Z-line, alpha 2 |
chr11_-_111781454 | 0.22 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr15_-_59041768 | 0.22 |
ENST00000402627.1
ENST00000396140.2 ENST00000559053.1 ENST00000561288.1 |
ADAM10
|
ADAM metallopeptidase domain 10 |
chrX_+_24483338 | 0.22 |
ENST00000379162.4
ENST00000441463.2 |
PDK3
|
pyruvate dehydrogenase kinase, isozyme 3 |
chr4_-_87028478 | 0.22 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
chr9_+_109685630 | 0.22 |
ENST00000451160.2
|
RP11-508N12.4
|
Uncharacterized protein |
chr7_+_134551583 | 0.21 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr4_-_175443484 | 0.21 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
chr5_+_42756903 | 0.21 |
ENST00000361970.5
ENST00000388827.4 |
CCDC152
|
coiled-coil domain containing 152 |
chr4_+_103790462 | 0.21 |
ENST00000503643.1
|
CISD2
|
CDGSH iron sulfur domain 2 |
chr16_-_46649905 | 0.21 |
ENST00000569702.1
|
SHCBP1
|
SHC SH2-domain binding protein 1 |
chr6_-_56492816 | 0.21 |
ENST00000522360.1
|
DST
|
dystonin |
chr5_-_142782862 | 0.21 |
ENST00000415690.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr22_+_40440804 | 0.21 |
ENST00000441751.1
ENST00000301923.9 |
TNRC6B
|
trinucleotide repeat containing 6B |
chr15_+_38964048 | 0.21 |
ENST00000560203.1
ENST00000557946.1 |
RP11-275I4.2
|
RP11-275I4.2 |
chr14_+_51026844 | 0.20 |
ENST00000554886.1
|
ATL1
|
atlastin GTPase 1 |
chr11_-_62323702 | 0.20 |
ENST00000530285.1
|
AHNAK
|
AHNAK nucleoprotein |
chrX_-_41449204 | 0.20 |
ENST00000378179.3
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
chr4_+_129732419 | 0.20 |
ENST00000510308.1
|
PHF17
|
jade family PHD finger 1 |
chr4_+_169013666 | 0.20 |
ENST00000359299.3
|
ANXA10
|
annexin A10 |
chr9_+_71986182 | 0.20 |
ENST00000303068.7
|
FAM189A2
|
family with sequence similarity 189, member A2 |
chr7_+_121513374 | 0.20 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
chr8_+_86999516 | 0.20 |
ENST00000521564.1
|
ATP6V0D2
|
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 |
chr9_+_67977438 | 0.20 |
ENST00000456982.1
|
RP11-195B21.3
|
Protein LOC644249 |
chr3_+_46449049 | 0.20 |
ENST00000357392.4
ENST00000400880.3 ENST00000433848.1 |
CCRL2
|
chemokine (C-C motif) receptor-like 2 |
chr12_-_68696652 | 0.20 |
ENST00000539972.1
|
MDM1
|
Mdm1 nuclear protein homolog (mouse) |
chr11_+_27062272 | 0.20 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr12_-_102591604 | 0.20 |
ENST00000329406.4
|
PMCH
|
pro-melanin-concentrating hormone |
chr22_+_46449674 | 0.20 |
ENST00000381051.2
|
FLJ27365
|
hsa-mir-4763 |
chr10_+_112631699 | 0.20 |
ENST00000444997.1
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
chr15_-_52944231 | 0.20 |
ENST00000546305.2
|
FAM214A
|
family with sequence similarity 214, member A |
chr11_-_112034803 | 0.20 |
ENST00000528832.1
|
IL18
|
interleukin 18 (interferon-gamma-inducing factor) |
chr16_-_67260691 | 0.20 |
ENST00000447579.1
ENST00000393992.1 ENST00000424285.1 |
LRRC29
|
leucine rich repeat containing 29 |
chr2_-_188419078 | 0.20 |
ENST00000437725.1
ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr3_-_186857267 | 0.19 |
ENST00000455270.1
ENST00000296277.4 |
RPL39L
|
ribosomal protein L39-like |
chr6_-_56716686 | 0.19 |
ENST00000520645.1
|
DST
|
dystonin |
chr1_-_150669500 | 0.19 |
ENST00000271732.3
|
GOLPH3L
|
golgi phosphoprotein 3-like |
chr7_+_77469439 | 0.19 |
ENST00000450574.1
ENST00000416283.2 ENST00000248550.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr9_+_26956474 | 0.19 |
ENST00000429045.2
|
IFT74
|
intraflagellar transport 74 homolog (Chlamydomonas) |
chr14_+_56127989 | 0.19 |
ENST00000555573.1
|
KTN1
|
kinectin 1 (kinesin receptor) |
chr9_+_131062367 | 0.19 |
ENST00000601297.1
|
AL359091.2
|
CDNA: FLJ21673 fis, clone COL09042; HCG2036511; Uncharacterized protein |
chr4_+_165675197 | 0.19 |
ENST00000515485.1
|
RP11-294O2.2
|
RP11-294O2.2 |
chr6_+_89790490 | 0.19 |
ENST00000336032.3
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr7_+_151791095 | 0.19 |
ENST00000422997.2
|
GALNT11
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11) |
chr12_+_21207503 | 0.19 |
ENST00000545916.1
|
SLCO1B7
|
solute carrier organic anion transporter family, member 1B7 (non-functional) |
chr1_-_109935819 | 0.19 |
ENST00000538502.1
|
SORT1
|
sortilin 1 |
chr12_+_72061563 | 0.19 |
ENST00000551238.1
|
THAP2
|
THAP domain containing, apoptosis associated protein 2 |
chr4_-_147443043 | 0.19 |
ENST00000394059.4
ENST00000502607.1 ENST00000335472.7 ENST00000432059.2 ENST00000394062.3 |
SLC10A7
|
solute carrier family 10, member 7 |
chr13_-_33002151 | 0.19 |
ENST00000495479.1
ENST00000343281.4 ENST00000464470.1 ENST00000380139.4 ENST00000380133.2 |
N4BP2L1
|
NEDD4 binding protein 2-like 1 |
chr1_+_47264711 | 0.18 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
chr10_+_112631547 | 0.18 |
ENST00000280154.7
ENST00000393104.2 |
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
chr12_-_79849240 | 0.18 |
ENST00000550268.1
|
RP1-78O14.1
|
RP1-78O14.1 |
chr6_-_88001706 | 0.18 |
ENST00000369576.2
|
GJB7
|
gap junction protein, beta 7, 25kDa |
chr4_+_95174445 | 0.18 |
ENST00000509418.1
|
SMARCAD1
|
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 |
chr5_+_81601166 | 0.18 |
ENST00000439350.1
|
ATP6AP1L
|
ATPase, H+ transporting, lysosomal accessory protein 1-like |
chr19_-_39402798 | 0.18 |
ENST00000571838.1
|
CTC-360G5.1
|
coiled-coil glutamate-rich protein 2 |
chr3_+_119316721 | 0.18 |
ENST00000488919.1
ENST00000495992.1 |
PLA1A
|
phospholipase A1 member A |
chr10_-_4720301 | 0.18 |
ENST00000449712.1
|
LINC00704
|
long intergenic non-protein coding RNA 704 |
chr1_-_89664595 | 0.18 |
ENST00000355754.6
|
GBP4
|
guanylate binding protein 4 |
chr6_+_47666275 | 0.18 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr9_-_86432547 | 0.18 |
ENST00000376365.3
ENST00000376371.2 |
GKAP1
|
G kinase anchoring protein 1 |
chr15_-_55790515 | 0.18 |
ENST00000448430.2
ENST00000457155.2 |
DYX1C1
|
dyslexia susceptibility 1 candidate 1 |
chr6_+_45296391 | 0.18 |
ENST00000371436.6
ENST00000576263.1 |
RUNX2
|
runt-related transcription factor 2 |
chr14_+_73563735 | 0.18 |
ENST00000532192.1
|
RBM25
|
RNA binding motif protein 25 |
chr8_-_72274355 | 0.18 |
ENST00000388741.2
|
EYA1
|
eyes absent homolog 1 (Drosophila) |
chr5_-_149465990 | 0.18 |
ENST00000543093.1
|
CSF1R
|
colony stimulating factor 1 receptor |
chrX_+_22056165 | 0.18 |
ENST00000535894.1
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr9_-_127710292 | 0.18 |
ENST00000421514.1
|
GOLGA1
|
golgin A1 |
chr5_+_139027877 | 0.18 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
chr11_-_108464465 | 0.18 |
ENST00000525344.1
|
EXPH5
|
exophilin 5 |
chr4_-_15683230 | 0.18 |
ENST00000515679.1
|
FBXL5
|
F-box and leucine-rich repeat protein 5 |
chr14_+_45464658 | 0.18 |
ENST00000555874.1
|
FAM179B
|
family with sequence similarity 179, member B |
chr17_-_74547256 | 0.18 |
ENST00000589145.1
|
CYGB
|
cytoglobin |
chr1_-_156269428 | 0.18 |
ENST00000339922.3
|
VHLL
|
von Hippel-Lindau tumor suppressor-like |
chr3_-_12200851 | 0.17 |
ENST00000287814.4
|
TIMP4
|
TIMP metallopeptidase inhibitor 4 |
chr18_-_53070913 | 0.17 |
ENST00000568186.1
ENST00000564228.1 |
TCF4
|
transcription factor 4 |
chr7_-_84122033 | 0.17 |
ENST00000424555.1
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr1_+_78470530 | 0.17 |
ENST00000370763.5
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4 |
chr3_-_121448791 | 0.17 |
ENST00000489400.1
|
GOLGB1
|
golgin B1 |
chr20_+_9049682 | 0.17 |
ENST00000334005.3
ENST00000378473.3 |
PLCB4
|
phospholipase C, beta 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 1.0 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.8 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.4 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.1 | 0.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.5 | GO:0009956 | radial pattern formation(GO:0009956) |
0.1 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.6 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 0.5 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.5 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 1.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.6 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.1 | 1.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.3 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.1 | 0.6 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.2 | GO:1905205 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.7 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.6 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.0 | 0.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.2 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 1.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.0 | 0.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.0 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.2 | GO:0042426 | choline catabolic process(GO:0042426) |
0.0 | 0.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.0 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.2 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.2 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.0 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.1 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.0 | GO:0001934 | positive regulation of protein phosphorylation(GO:0001934) |
0.0 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.1 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.0 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.0 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.1 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.0 | 0.1 | GO:0042245 | RNA repair(GO:0042245) |
0.0 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.1 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.0 | 0.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.1 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.1 | GO:0002765 | negative regulation of type IV hypersensitivity(GO:0001808) immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.0 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.1 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.0 | 0.1 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.0 | 0.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.1 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:1902990 | leading strand elongation(GO:0006272) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.0 | 0.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.0 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.1 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.0 | 0.1 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 0.1 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
0.0 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.0 | 0.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 0.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.1 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.1 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.0 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.1 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.2 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.0 | 0.0 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.0 | 0.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.0 | 0.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.0 | 0.0 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.0 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.2 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.9 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.4 | GO:0031673 | H zone(GO:0031673) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.1 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.0 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.2 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.8 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.4 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.1 | 0.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.1 | 0.5 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.1 | 0.2 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.3 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.1 | 0.4 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.0 | 0.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.0 | 0.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 0.1 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.3 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.1 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.0 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.2 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
0.0 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.7 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0070260 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.0 | 0.1 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.0 | 0.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0032427 | GBD domain binding(GO:0032427) |
0.0 | 0.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.4 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.0 | 0.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.2 | GO:0019887 | protein kinase inhibitor activity(GO:0004860) kinase regulator activity(GO:0019207) kinase inhibitor activity(GO:0019210) protein kinase regulator activity(GO:0019887) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.0 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 1.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |